• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

成功实施布氏不动杆菌复合群消除方案在囊性纤维化患者中的应用。

Implementation of a successful eradication protocol for Burkholderia Cepacia complex in cystic fibrosis patients.

机构信息

Department of Medicine, Division of Allergy, Pulmonary and Critical Care Medicine, 1900 University Blvd, THT 422, Birmingham, AL, 35294, USA.

Gregory Fleming James Cystic Fibrosis Research Center, Birmingham, AL, USA.

出版信息

BMC Pulm Med. 2018 Feb 14;18(1):35. doi: 10.1186/s12890-018-0594-8.

DOI:10.1186/s12890-018-0594-8
PMID:29444656
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5813405/
Abstract

BACKGROUND

Infection with Burkholderia cepacia complex (Bcc) results in a heterogeneous clinical course ranging from asymptomatic colonization of the airways to fulminant respiratory failure in patients with cystic fibrosis (CF). Early eradication of Pseudomonas aeruginosa improves clinical outcomes. The efficacy and clinical outcomes following implementation of an eradication protocol for Bcc are less well understood.

METHODS

We developed and implemented a single center Bcc eradication protocol that included an intensive combination of intravenous, inhaled, and oral antibiotic therapies based on in vitro sensitivities. We conducted a retrospective cohort analysis of clinical outcomes compared to patients with chronic Bcc infection.

RESULTS

Six patients were identified as having a newly acquired Bcc colonization and were placed on the eradication protocol. Sequential sputum samples after completion of the protocol demonstrated sustained clearance of Bcc in all patients. Lung function and nutritional status remained stable in the year following eradication.

CONCLUSION

Clearance of Bcc from sputum cultures using a standardized protocol was successful at one year and was associated with clinical stability.

摘要

背景

洋葱伯克霍尔德菌复合群(Bcc)感染可导致从无症状的气道定植到囊性纤维化(CF)患者暴发性呼吸衰竭等不同的临床病程。早期清除铜绿假单胞菌可改善临床结局。实施 Bcc 清除方案后的疗效和临床结局了解较少。

方法

我们制定并实施了一项单中心 Bcc 清除方案,该方案基于体外药敏试验,包括静脉、吸入和口服抗生素的强化联合治疗。我们对临床结局进行了回顾性队列分析,并与慢性 Bcc 感染患者进行了比较。

结果

确定了 6 例新发生的 Bcc 定植患者,并采用清除方案进行治疗。方案完成后连续的痰标本检测显示所有患者均持续清除 Bcc。清除后一年,肺功能和营养状况保持稳定。

结论

使用标准化方案从痰培养中清除 Bcc 在一年时是成功的,且与临床稳定性相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a720/5813405/96bb165cfc30/12890_2018_594_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a720/5813405/8d4bb9637b6e/12890_2018_594_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a720/5813405/96bb165cfc30/12890_2018_594_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a720/5813405/8d4bb9637b6e/12890_2018_594_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a720/5813405/96bb165cfc30/12890_2018_594_Fig2_HTML.jpg

相似文献

1
Implementation of a successful eradication protocol for Burkholderia Cepacia complex in cystic fibrosis patients.成功实施布氏不动杆菌复合群消除方案在囊性纤维化患者中的应用。
BMC Pulm Med. 2018 Feb 14;18(1):35. doi: 10.1186/s12890-018-0594-8.
2
Two case reports of the successful eradication of new isolates of Burkholderia cepacia complex in children with cystic fibrosis.两例成功根除囊性纤维化患儿中新分离出的洋葱伯克霍尔德菌复合体的病例报告。
BMC Pharmacol Toxicol. 2016 Mar 28;17:14. doi: 10.1186/s40360-016-0054-0.
3
Can early Burkholderia cepacia complex infection in cystic fibrosis be eradicated with antibiotic therapy?囊性纤维化患者中早发伯克霍尔德菌复合感染能否通过抗生素治疗根除?
Front Cell Infect Microbiol. 2011 Dec 21;1:18. doi: 10.3389/fcimb.2011.00018. eCollection 2011.
4
Management of initial colonisations with Burkholderia species in France, with retrospective analysis in five cystic fibrosis Centres: a pilot study.法国伯克霍尔德菌初始定植的管理:五个囊性纤维化中心的回顾性分析:一项初步研究。
BMC Pulm Med. 2020 Jun 5;20(1):159. doi: 10.1186/s12890-020-01190-y.
5
Successful treatment of cepacia syndrome with a combination of intravenous cyclosporin, antibiotics and oral corticosteroids.环孢素静脉注射、抗生素和口服皮质类固醇联合治疗洋葱伯克霍尔德菌综合征获得成功。
J Cyst Fibros. 2012 Sep;11(5):458-60. doi: 10.1016/j.jcf.2012.04.002. Epub 2012 May 1.
6
When is Burkholderia cepacia complex truly eradicated in adults with cystic fibrosis? A 20-year follow up study.当囊性纤维化成人中的伯克霍尔德菌复合群真正被根除时?一项 20 年的随访研究。
J Cyst Fibros. 2024 Jan;23(1):87-90. doi: 10.1016/j.jcf.2023.09.016. Epub 2023 Sep 28.
7
Combination aerosol therapy to treat Burkholderia cepacia complex.联合雾化疗法治疗洋葱伯克霍尔德菌复合体。
Eur Respir J. 2005 Aug;26(2):305-8. doi: 10.1183/09031936.05.00119504.
8
The first reported case of Burkholderia contaminans in patients with cystic fibrosis in Ireland: from the Sargasso Sea to Irish Children.爱尔兰囊性纤维化患者中首例伯克霍尔德菌污染病例报告:从马尾藻海到爱尔兰儿童。
BMC Pulm Med. 2016 Apr 22;16(1):57. doi: 10.1186/s12890-016-0219-z.
9
Antibiotic therapy for chronic infection with Burkholderia cepacia complex in people with cystic fibrosis.囊性纤维化患者中针对洋葱伯克霍尔德菌复合群慢性感染的抗生素治疗。
Cochrane Database Syst Rev. 2019 Jun 13;6(6):CD013079. doi: 10.1002/14651858.CD013079.pub2.
10
Novel antibiotic combinations proposed for treatment of complex infections.新型抗生素组合方案用于治疗复杂感染。
Antimicrob Resist Infect Control. 2017 Nov 25;6:120. doi: 10.1186/s13756-017-0279-8. eCollection 2017.

引用本文的文献

1
Isolation of complex in adults with primary ciliary dyskinesia.成人原发性纤毛运动障碍患者复合体的分离
ERJ Open Res. 2024 Dec 9;10(6). doi: 10.1183/23120541.00282-2024. eCollection 2024 Nov.
2
Phage therapy to treat cystic fibrosis complex lung infections: perspectives and challenges.噬菌体疗法治疗囊性纤维化复杂肺部感染:前景与挑战
Front Microbiol. 2024 Oct 18;15:1476041. doi: 10.3389/fmicb.2024.1476041. eCollection 2024.
3
Efficacy of combination antibiotic therapy including inhaled tobramycin on pneumonia in a non-cystic fibrosis patient.

本文引用的文献

1
Two case reports of the successful eradication of new isolates of Burkholderia cepacia complex in children with cystic fibrosis.两例成功根除囊性纤维化患儿中新分离出的洋葱伯克霍尔德菌复合体的病例报告。
BMC Pharmacol Toxicol. 2016 Mar 28;17:14. doi: 10.1186/s40360-016-0054-0.
2
Impact of Sustained Eradication of New Pseudomonas aeruginosa Infection on Long-term Outcomes in Cystic Fibrosis.持续根除新的铜绿假单胞菌感染对囊性纤维化长期预后的影响
Clin Infect Dis. 2015 Sep 1;61(5):707-15. doi: 10.1093/cid/civ377. Epub 2015 May 13.
3
Eradication therapy for Burkholderia cepacia complex in people with cystic fibrosis.
包括吸入用妥布霉素在内的联合抗生素疗法对非囊性纤维化患者肺炎的疗效。
IDCases. 2024 Sep 9;38:e02081. doi: 10.1016/j.idcr.2024.e02081. eCollection 2024.
4
Mutations Affecting Cellular Levels of Cobalamin (Vitamin B) Confer Tolerance to Bactericidal Antibiotics in .影响钴胺素(维生素 B)细胞水平的突变赋予 对杀菌抗生素的耐受性。
J Microbiol Biotechnol. 2024 Aug 28;34(8):1609-1616. doi: 10.4014/jmb.2406.06028. Epub 2024 Jul 11.
5
Profiling cell envelope-antibiotic interactions reveals vulnerabilities to β-lactams in a multidrug-resistant bacterium.分析细胞包膜-抗生素相互作用揭示了多药耐药菌对β-内酰胺类抗生素的敏感性。
Nat Commun. 2023 Aug 9;14(1):4815. doi: 10.1038/s41467-023-40494-5.
6
Eradication of complex in cystic fibrosis patients with inhalation of amiloride and tobramycin combined with oral cotrimoxazole.吸入阿米洛利和妥布霉素联合口服复方新诺明根除囊性纤维化患者的复合体。
ERJ Open Res. 2023 Jun 26;9(3). doi: 10.1183/23120541.00055-2023. eCollection 2023 May.
7
Brazilian guidelines for the pharmacological treatment of the pulmonary symptoms of cystic fibrosis. Official document of the Sociedade Brasileira de Pneumologia e Tisiologia (SBPT, Brazilian Thoracic Association).巴西囊性纤维化肺部症状药物治疗指南。巴西胸科学会(SBPT)官方文件。
J Bras Pneumol. 2023 May 15;49(2):e20230040. doi: 10.36416/1806-3756/e20230040. eCollection 2023.
8
Gradients in gene essentiality reshape antibacterial research.基因必需性梯度重塑抗菌研究。
FEMS Microbiol Rev. 2022 May 6;46(3). doi: 10.1093/femsre/fuac005.
9
Cystic Fibrosis: Recent Insights into Inhaled Antibiotic Treatment and Future Perspectives.囊性纤维化:吸入性抗生素治疗的最新见解与未来展望
Antibiotics (Basel). 2021 Mar 22;10(3):338. doi: 10.3390/antibiotics10030338.
10
Burkholderia ubonensis High-Level Tetracycline Resistance Is Due to Efflux Pump Synergy Involving a Novel TetA(64) Resistance Determinant.乌汶伯克霍尔德菌高水平四环素耐药性是由于新型 TetA(64)耐药决定簇的外排泵协同作用所致。
Antimicrob Agents Chemother. 2021 Feb 17;65(3). doi: 10.1128/AAC.01767-20.
针对囊性纤维化患者的洋葱伯克霍尔德菌复合群根除疗法。
Cochrane Database Syst Rev. 2014 Oct 24(10):CD009876. doi: 10.1002/14651858.CD009876.pub2.
4
Factors influencing acquisition of Burkholderia cepacia complex organisms in patients with cystic fibrosis.影响囊性纤维化患者感染洋葱伯克霍尔德菌复合体微生物的因素。
J Clin Microbiol. 2013 Dec;51(12):3975-80. doi: 10.1128/JCM.01360-13. Epub 2013 Sep 18.
5
Factors associated with FEV1 decline in cystic fibrosis: analysis of the ECFS patient registry.与囊性纤维化患者 FEV1 下降相关的因素:对 ECFS 患者注册中心的分析。
Eur Respir J. 2014 Jan;43(1):125-33. doi: 10.1183/09031936.00166412. Epub 2013 Apr 18.
6
Can early Burkholderia cepacia complex infection in cystic fibrosis be eradicated with antibiotic therapy?囊性纤维化患者中早发伯克霍尔德菌复合感染能否通过抗生素治疗根除?
Front Cell Infect Microbiol. 2011 Dec 21;1:18. doi: 10.3389/fcimb.2011.00018. eCollection 2011.
7
Comparison of two treatment regimens for eradication of Pseudomonas aeruginosa infection in children with cystic fibrosis.两种治疗方案治疗囊性纤维化患儿铜绿假单胞菌感染的比较。
J Cyst Fibros. 2013 Jan;12(1):29-34. doi: 10.1016/j.jcf.2012.06.001. Epub 2012 Jul 2.
8
Can Burkholderia cepacia complex be eradicated with nebulised amiloride and TOBI?雾化用氨氯吡脒和妥布霉素能否根除洋葱伯克霍尔德菌复合体?
J Cyst Fibros. 2010 Jan;9(1):73-4. doi: 10.1016/j.jcf.2009.11.001. Epub 2009 Nov 22.
9
Cystic fibrosis pulmonary guidelines: treatment of pulmonary exacerbations.囊性纤维化肺部指南:肺部急性加重的治疗
Am J Respir Crit Care Med. 2009 Nov 1;180(9):802-8. doi: 10.1164/rccm.200812-1845PP. Epub 2009 Sep 3.
10
Infection with Burkholderia cepacia complex bacteria and pulmonary exacerbations of cystic fibrosis.洋葱伯克霍尔德菌复合体细菌感染与囊性纤维化的肺部加重
Chest. 2007 Apr;131(4):1188-96. doi: 10.1378/chest.06-2611.